4-[2,3-difluoro-6-(2-fluoro-4-methyl-phe nylsulfanyl)-phenyl]-piperidine

Details for Australian Patent Application No. 2008338058 (hide)

Owner H. Lundbeck A/S

Inventors Faldt, Andre; Jorgensen, Morten; BangAndersen, Benny; Stensbol, Tine Bryan; Anderson, Neil

Agent Watermark

Pub. Number AU-A-2008338058

PCT Pub. Number WO2009/076961

Priority 61/013,892 14.12.07 US; PA 200701792 14.12.07 DK

Filing date 11 December 2008

Wipo publication date 25 June 2009

International Classifications

C07D 211/20 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/451 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

8 July 2010 PCT application entered the National Phase

  PCT publication WO2009/076961 Priority application(s): WO2009/076961

21 October 2010 Amendment Made

  The nature of the amendment is: Amend the priority details to delete priority details under INID(31) 61/013,893

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008338059-Therapeutic uses of compounds having affinity to the serotonin transporter, serotonin receptors and noradrenalin transporter

2008338029-Reverse iron ore flotation by collectors in aqueous nanoemulsion